menu search

AGN / AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News

AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News
AbbVie Inc's unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of its opioid painkiller, Bloomberg News reported on Wednesday, citing people familiar with the matter. Read More
Posted: Jul 27 2022, 18:18
Author Name: Reuters
Views: 102087

AGN News  

AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News

By Reuters
July 27, 2022

AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News

AbbVie Inc's unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of its opioid pai more_horizontal

Allergan Shares Topline Data For Twice Daily Vuity (Pilocarpine) In Blurry Vision Study

By Benzinga
April 5, 2022

Allergan Shares Topline Data For Twice Daily Vuity (Pilocarpine) In Blurry Vision Study

Allergan, an AbbVie Inc (NYSE: ABBV) company, announced topline data from Phase 3 VIRGO trial evaluating Vuity (pilocarpine HCl ophthalmic solution) more_horizontal


Search within

Pages Search Results: